DCT and neoplasm: The combination of PMG5 and Ad5-TRP2 as a therapeutic treatment in B16.F10-challenged mice demonstrated significantly higher survival (compared to untreated mice) as well as reduced tumor burden and protection from future tumor challenges, implying that immunological memory was generated.